Rituximab Biosimilar, Human IgG4 S228P Mutant

The rituximab biosimilar, human IgG4 S228P mutant, can be used for ELISA, neutralization, in vitro and in vivo functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by rituximab. The rituximab Biosimilar, Human IgG4 S228P Mutant, is for research use only.

Synonyms: B-lymphocyte antigen CD20, MS4A1, B1, Bp35, CVID5, LEU-16, MS4A2, S7, membrane spanning 4-domains A1, FMC7, cluster of differentiate 20